Suicide attempts in adolescents with cystic fibrosis on Elexacaftor/Tezacaftor/Ivacaftor therapy - Arslan M, Chalmers S, Rentfrow K, Olson JM, Dean V, Wylam ME, Demirel N.

Elexacaftor/Tezacaftor/Ivacaftor (ETI) is a recently approved cystic fibrosis (CF) transmembrane conductance regulator modulator therapy that has shown promising clinical and laboratory improvements on multiple organ systems in people with CF (pwCF). While...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news